apl 400-003
Vaccineexperimental
Clinical trial activity
6 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 1996 (NCT00001538)
Timeline
1990s
- Jan 1, 1996
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- apl 400-003
- apl 400-047
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00001090 | Phase 1 | Nov 2, 1999 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT00002231 | Phase 1 | Nov 2, 1999 | Wyeth |
| NCT00002232 | Phase 1 | Nov 2, 1999 | Wyeth |
| NCT00002350 | Phase 1 | Nov 2, 1999 | Apollon |
| NCT00001088 | Phase 1 | Jul 1, 1997 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT00001538 | Phase 1 | Mar 1, 1996 | National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 3 | 3 | 1 | 1996 |
| Wyeth | For profit | 2 | 2 | 1 | 1999 |
| Apollon | For profit | 1 | 1 | 1 | 1999 |
3 organizations
Page 1 / 1